Related Experiment Video

Updated: Nov 8, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.3K

BRCA1 degradation in response to mitochondrial damage in breast cancer cells

Kana Miyahara1, Naoharu Takano2, Yumiko Yamada3

  • 1Department of Breast Oncology and Surgery, Tokyo Medical University, Shinjuku, Tokyo, 160-8402, Japan.

Scientific Reports
|April 23, 2021
PubMed

Insights

Mitochondrial damage triggers the PINK1/Parkin pathway, leading to BRCA1 protein degradation in breast cancer cells. This BRCA1 loss promotes DNA damage and impacts cancer progression.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • BRCA1 is a crucial tumor suppressor in DNA repair.
  • PINK1 and Parkin are key in mitochondrial quality control and Parkinson's disease.
  • Mitochondrial dysfunction is increasingly linked to cancer.

Purpose of the Study:

  • To investigate the link between mitochondrial damage and BRCA1 stability in breast cancer.
  • To elucidate the role of PINK1 and Parkin in BRCA1 degradation.
  • To explore the clinical relevance of BRCA1 and mitochondrial proteins in breast cancer.

Main Methods:

  • Utilized breast cancer cell lines treated with mitochondrial targeting reagents.
  • Assessed BRCA1 protein levels and DNA damage markers.
  • Investigated protein-protein interactions using co-immunoprecipitation.
  • Analyzed patient data for correlations between gene expression and survival.

Main Results:

  • Mitochondrial depolarization and PINK1 upregulation induced proteasomal degradation of BRCA1.
  • BRCA1 degradation was dependent on PINK1 and mediated by Parkin.
  • BRCA1 downregulation led to increased DNA double-strand breaks.
  • BRCA1 and PINK1/Parkin expression were inversely correlated in patient tumors.
  • BRCA1 knockdown inhibited cancer cell growth, while high BRCA1 predicted poor survival.

Conclusions:

  • Mitochondrial damage signals nuclear BRCA1 degradation via the PINK1/Parkin pathway.
  • This pathway represents a novel mechanism linking mitochondrial health to genomic stability in cancer.
  • BRCA1 downregulation due to mitochondrial dysfunction may contribute to breast cancer progression and poor prognosis.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA108:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

14.9K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.7K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
16.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.6K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
14.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K